p.121 抽出テキスト

526. Murphy DA, Finlayson DC, Craver JM, et al. Effect of positive end-expiratory pressure on excessive mediastinal bleeding after cardiac operations. A controlled study. J Thorac Cardiovasc Surg 1983; 85: 864-869. PMID: 6343729 527. Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944-982. PMID: 21353044 528. Alghamdi AA, Albanna MJ, Guru V, et al. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. J Card Surg 2006; 21: 320-326. PMID: 16684074 529. Haydar AA, Abchee AB, El-Hajj II, et al. Bleeding post coronary artery bypass surgery. Clopidogrel--cure or culprit? J Med Liban 2006; 54: 11-16. PMID: 17044627 530. Vaccarino GN, Thierer J, Albertal M, et al. Impact of preoperative clopidogrel in off pump coronary artery bypass surgery: a propensity score analysis. J Thorac Cardiovasc Surg 2009; 137: 309-313. PMID: 19185143 531. Siller-Matula JM, Petre A, Delle-Karth G, et al. Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care 2017; 6: 753-770. PMID: 25943554 532. Mangano DT, Tudor IC, Dietzel C, et al. Multicenter Study of Perioperative Ischemia Research Group. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354: 353-365. PMID: 16436767 533. Mangano DT, Miao Y, Vuylsteke A, et al. Investigators of The Multicenter Study of Perioperative Ischemia Research Group. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007; 297: 471-479. PMID: 17284697 534. Fergusson DA, Hébert PC, Mazer CD, et al. BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-2331. PMID: 18480196 535. Henry D, Carless P, Fergusson D, et al. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ 2009; 180: 183-193. PMID: 19050037 536. Santos AT, Kalil RA, Bauemann C, et al. A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting. Braz J Med Biol Res 2006; 39: 63-69. PMID: 16400465 537. Weisel RD, Charlesworth DC, Mickleborough LL, et al. Limitations of blood conservation. J Thorac Cardiovasc Surg 1984; 88: 26-38. PMID: 6376959 538. van Woerkens EC, Trouwborst A, van Lanschot JJ. Profound hemodilution: what is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human? Anesth Analg 1992; 75: 818-821. PMID: 1416137 539. Hébert PC, Yetisir E, Martin C, et al. Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001; 29: 227-234. PMID: 11246298 540. Mazer CD, Whitlock RP, Fergusson DA, et al. TRICS Investigators and Perioperative Anesthesia Clinical Trials Group. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med 2017; 377: 2133-2144. PMID: 29130845 541. 日本輸血・細胞治療学会. 科学的根拠に基づいた赤血球製剤の使用ガイドライン. 2016. http://yuketsu.jstmct.or.jp/medical/guidelines/ 542. Murphy GJ, Pike K, Rogers CA, et al. TITRe2 Investigators. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015; 372: 997-1008. PMID: 25760354 543. Carson JL, Brooks MM, Abbott JD, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J 2013; 165: 964-971.e1. PMID: 23708168 544. Wang Y, Shi X, Wen M, et al. Restrictive versus liberal blood transfusion in patients with coronary artery disease: a meta-analysis. Curr Med Res Opin 2017; 33: 761-768. PMID: 28067544 545. Patel NN, Avlonitis VS, Jones HE, et al. Indications for red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis. Lancet Haematol 2015; 2: e543-e553. PMID: 26686409 546. Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345: 1230-1236. PMID: 11680442 547. Consten EC, Henny CP, Eijsman L, et al. The routine use of fresh frozen plasma in operations with cardiopulmonary bypass is not justified. J Thorac Cardiovasc Surg 1996; 112: 162-167. PMID: 8691863 548. Kasper SM, Giesecke T, Limpers P, et al. Failure of autologous fresh frozen plasma to reduce blood loss and transfusion requirements in coronary artery bypass surgery. Anesthesiology 2001; 95: 81-86. PMID: 11465588 549. Stanworth SJ, Brunskill SJ, Hyde CJ, et al. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004; 126: 139-152. PMID: 15198745 550. Casbard AC, Williamson LM, Murphy MF, et al. The role of prophylactic fresh frozen plasma in decreasing blood loss and correcting coagulopathy in cardiac surgery. A systematic review. Anaesthesia 2004; 59: 550-558. PMID: 15144294 551. Lytle BW, Loop FD, Cosgrove DM, et al. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 1985; 89: 248-258. PMID: 2857209 552. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986; 314: 1-6. PMID: 3484393 553. Boylan MJ, Lytle BW, Loop FD, et al. Surgical treatment of isolated left anterior descending coronary stenosis. Comparison of left internal mammary artery and venous autograft at 18 to 20 years of follow-up. J Thorac Cardiovasc Surg 1994; 107: 657-662. PMID: 8127094 554. Kitamura S, Kawachi K, Taniguchi S, et al. Long-term benefits of internal thoracic artery-coronary artery bypass in Japanese patients. Jpn J Thorac Cardiovasc Surg 1998; 46: 1-10. PMID: 9513518 555. Cameron AA, Green GE, Brogno DA, et al. Internal thoracic artery grafts: 20-year clinical follow-up. J Am Coll Cardiol 1995; 25: 188- 192. PMID: 7798499 556. Zeff RH, Kongtahworn C, Iannone LA, et al. Internal mammary artery versus saphenous vein graft to the left anterior descending coronary artery: prospective randomized study with 10-year follow-up. Ann Thorac Surg 1988; 45: 533-536. PMID: 3259128 557. Dabal RJ, Goss JR, Maynard C, et al. The effect of left internal mammary artery utilization on short-term outcomes after coronary revascularization. Ann Thorac Surg 2003; 76: 464-470. PMID: 12902086 558. Grover FL, Johnson RR, Marshall G, et al. Impact of mammary grafts on coronary bypass operative mortality and morbidity. Department of Veterans Affairs Cardiac Surgeons. Ann Thorac Surg 1994; 57: 559-569. PMID: 8147622 559. Hlatky MA, Boothroyd DB, Reitz BA, et al. Adoption and effectiveness of internal mammary artery grafting in coronary artery bypass surgery among Medicare beneficiaries. J Am Coll Cardiol 2014; 63: 33-39. PMID: 24080110 560. Sabik JF, Blackstone EH, Gillinov AM, et al. Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. J Thorac Cardiovasc Surg 2006; 131: 90-98. PMID: 16399299 561. Shah PJ, Durairaj M, Gordon I, et al. Factors affecting patency of internal thoracic artery graft: clinical and angiographic study in 1434 symptomatic patients operated between 1982 and 2002. Eur J Cardiothorac Surg 2004; 26: 118-124. PMID: 15200989 562. Shah PJ, Bui K, Blackmore S, et al. Has the in situ right internal thoracic artery been overlooked? An angiographic study of the radial artery, internal thoracic arteries and saphenous vein graft patencies in symptomatic patients. Eur J Cardiothorac Surg 2005; 27: 870-875. PMID: 15848328 563. Kawata T, Taniguchi S, Nishioka H, et al. Benefits accruing to grafting of the right internal thoracic artery to the left anterior descending artery in coronary artery bypass grafting. Jpn J Thorac Cardiovasc Surg 1999; 47: 388-393. PMID: 10496063 564. Mert M, Yildiz CE, Arat-Ozkan A, et al. Mid to long-term results of circumflex coronary artery revascularization with left internal thoracic artery grafts. Jpn Heart J 2004; 45: 23-30. PMID: 14973347 565. Higami T, Yamashita T, Nohara H, et al. Early results of coronary grafting using ultrasonically skeletonized internal thoracic arteries. Ann Thorac Surg 2001; 71: 1224-1228. PMID: 11308164 566. Sá MP, Ferraz PE, Escobar RR, et al. Skeletonized versus pedicled internal thoracic artery and risk of sternal wound infection after coronary bypass surgery: meta-analysis and meta-regression of 4817 patients. Interact Cardiovasc Thorac Surg 2013; 16: 849-857. PMID: 23446674 567. Kamiya H, Akhyari P, Martens A, et al. Sternal microcirculation after skeletonized versus pedicled harvesting of the internal thoracic artery: a randomized study. J Thorac Cardiovasc Surg 2008; 135: 32-37. PMID: 18179915 568. Sá MP, Soares EF, Santos CA, et al. Skeletonized left internal thoracic artery is associated with lower rates of mediastinitis in diabetic patients. Rev Bras Cir Cardiovasc 2011; 26: 183-189. PMID: 21894407 569. Kieser TM, Rose MS, Aluthman U, et al. Toward zero: deep sternal wound infection after 1001 consecutive coronary artery bypass procedures using arterial grafts: implications for diabetic patients. J Thorac Cardiovasc Surg 2014; 148: 1887-1895. PMID: 24613159 570. Wendler O, Tscholl D, Huang Q, et al. Free flow capacity of skeletonized versus pedicled internal thoracic artery grafts in coronary artery